Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Siren, L.L.C. | 8.50M | $14.0M | 4.66% | -- | 2026-06-30 |
| BlackRock, Inc. | 7.79M | $13.0M | 4.27% | +5.74M | 2026-06-30 |
| Softbank Group Corp. | 6.09M | $10.0M | 3.34% | -- | 2026-06-30 |
| Tudor Investment Corp ET AL | 5.19M | $8.0M | 2.84% | +3.86M | 2026-06-30 |
| Vanguard Capital Management LLC | 4.67M | $7.0M | 2.56% | +777.7K | 2026-06-30 |
| MIC Capital Management UK LLP | 4.46M | $7.0M | 2.44% | -- | 2026-06-30 |
| FMR LLC | 3.50M | $5.0M | 1.92% | +211 | 2026-06-30 |
| WELLCOME Trust Ltd (THE) as trustee of the WELLCOME Trust | 3.31M | $5.0M | 1.81% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 2.61M | $4.0M | 1.43% | +1.52M | 2026-06-30 |
| Two Sigma Investments, LP | 2.24M | $3.0M | 1.23% | -- | 2026-06-30 |
